Sponsor Deadline
Posted: 2/1/2023

Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites applications proposing to establish new, or significantly expand existing, interdisciplinary collaborations involving both experimental and computational researchers to simultaneously address a targeted research question in brain aging and Alzheimer's disease (AD), including AD-related dementias (ADRD).

This FOA utilizes the R21/R33 Phased Innovation Award activity code. The R21 phase provides up to 2 years of support for initial developmental activities. The R33 phase provides up to 3 years of support for expanded activities.

The aim of this initiative is for investigators to develop a sustainable, interdisciplinary collaboration across experimental and computational laboratories to support projects that address key research questions in brain aging and AD/ADRD.


  • Letter of Intent Due Date(s): August 22, 2023

  • Application Due Date: September 22, 2023

RFA-AG-24-018 Expiration Date September 23, 2023

Amount Description

For the R21 phase, the combined budget for direct costs for a two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

For the R33 phase, application budgets must remain under $500,000 in annual direct costs.